What will it take for pharma to get the drug-pricing monkey off its back? The pharmaceutical industry is in an awkward position. At the top of the list? A research report this month laid out the pricing landscape, tensions and problems pharma companies face. The unrivaled access U.S. patients enjoy comes at a cost.
What will it take for pharma to get the drug-pricing monkey off its back? The pharmaceutical industry is in an awkward position. At the top of the list? The unrivaled access U.S. patients enjoy comes at a cost.